UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 18, 2017
SPECTRASCIENCE, INC.
(Exact name of registrant as specified in its charter)
Minnesota | 000-13092 | 41-1448837 | ||
(State or Other Jurisdiction | (Commission | (I.R.S. Employer | ||
of Incorporation) | File Number) | Identification Number) |
11568-11 Sorrento Valley Road, | ||
San Diego, California | 92121 | |
(Address of Principal Executive Offices) | (Zip Code) |
(858) 847-0200 |
(Registrant’s Telephone Number, Including Area Code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
The issuer has decided not to proceed with the tender offer filed with the Securities and Exchange Commission on Form TO on August 19, 2016.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SPECTRASCIENCE, INC. | ||
By: | /s/ LOWEL W. GIFFHORN | |
Lowell W. Giffhorn | ||
Chief Financial Officer |
Dated: January 18, 2017